International Journal of Tuberculosis and Lung Disease

Article	Citations
Dr Christopher Zishiri	190
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	136
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	65
TB-related deaths among adults in Guinea-Bissau	60
New approaches to improve communication and adherence to treatment of TB infection in migrants	45
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	45
Launch of a second wave of IJTLD Clinical Standards for Lung Health	37
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	34
CFU counting may underestimate TB bacilli number of blood, biasing limit of detection estimates in spiking experiments	33
TB in ageing populations: lessons from Japan and Korea	27
The impact of sputum quality on Xpert positivity in active case-finding for TB	23
Screening of refugees from Ukraine for TB: a TBnet survey	21
TB infection in adults with diabetes mellitus in Uganda	21
Yield of community outreach events for TB screening	20
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	19
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	18
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	18
Latent TB and depressive symptoms in household contacts of persons with active TB	18
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	17
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	17
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	17
Occupational transmission of TB infection during autopsy	16
Standards for clinical trials for treating TB	16
The COVID-19 pandemic does not bode well for TB control	16
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	16

Are schools prepared to manage students with an asthma attack?	15
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	15
Literature Highlights	15
Mycobacteria susceptibility to epetraborole: how far can it go?	14
Assessment of TB patient cost – what about the mitigation strategy?	14
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	14
Accessibility and TB patient satisfaction in Nigeria	13
Improving the multidimensional scoring systems in bronchiectasis: the role of cellular biomarkers	13
Perceived stigma among people with TB and household contacts	13
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	13
Patterns of TB transmission in the United States, 2011–2017	12
A cohort study exploring variables associated with mortality in critically ill TB patients	12
Performance of spirometry assessment at TB diagnosis	12
Clinical standards for the diagnosis and management of asthma in low- and middle-income countries	11
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	11
A novel method for contact tracing for TB at household and community level	11
Decentralising TB diagnosis and contact management: impact on detection and preventive treatment in children	11
Factors associated with false-negative for T-SPOT.TB in patients with TB disease	11
Paediatric TB care in the United Kingdom	11
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	11
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	10
How incarceration can amplify TB: a preventable public health failure in Ecuador	10
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	10
Facilitators and barriers to adolescent participation in a TB clinical trial	10
Health status of Italian children living close to cultivations sprayed with pesticides	10
Population attributable fraction for smoking and diabetes in TB	10
The prevalence of post-TB bronchiectasis: lessons from the Spanish registeries	10
Post-TB lung disease: keep going beyond TB!	9
TB disease yield from household contact screening of TB index patients in Pakistan	9
Work efficiency at treatment completion for TB: addressing issues beyond bacteriological cure	9
Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?	9
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta	9
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB	9
Risk factors for severe COPD exacerbation in Chinese adults	9
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	9
If you want to go far, go together: standardisation and data sharing in TB drug development	8
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine	8
Lower TB notification rates in later life in the same birth cohort, Japan, 1950–2020	8
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease	8
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	8
Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan	8
TB notifications among citizens and non-citizens in Taiwan	8
Meeting of two pandemics in prison: a challenging event in a challenging environment	8
Cascade of care for people with TB and diabetes in India	8
Use of computed tomography for the diagnosis of TB during a paediatric outbreak	8
Perceived stigma related to TB preventive therapy	8
Community-based intervention and health education to scale up TB preventive treatment for children	8
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	7
The diagnostic accuracy of interferon-gamma release assay for TB infection in children under 5 years: a systematic review with meta-analysis	7
Non-TB mycobacterial diseases: negligence or helplessness?	7

Effect of biological therapies on TB treatment outcomes	7
Mycobacterium tuberculosis genotypes isolated from clinical specimens of extrapulmonary TB	7
A new understanding of clinical patterns in post-TB lung disease	7
The high costs facing TB-affected households in Mali	7
Predictors of TB disease in HIV-exposed children from Southern Africa	7
Proportions of Xpert MTB/RIF Ultra ‘trace’ results vary widely among different populations with presumptive TB	7
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB	7
Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration	7
Paediatric formulations for the treatment of drug resistant TB: closing the gaps	7
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease	7
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil	7
Contribution of Xpert® MTB/RIF to pediatric TB diagnosis in Mozambique	7
Diabetes characteristics and long-term management needs in diabetic TB patients	6
TB and COVID-19 co-infection in a pulmonology hospital	6
Extemporaneously compounded liquid formulations of clofazimine	6
Estimating TB survival ‐ mind the immortal-time gap	6
Literature Highlights	6
Sputum pooling for rapid and cost-effective active case-finding for TB in prisons	6
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	6
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	6
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease	6
Use of stool swabs in molecular transport media increases access to Xpert Ultra testing for TB in children	6
Acceptability of long-acting injectables for TB preventative treatment among high-risk groups	6
Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan	6
High prevalence of multidrug-resistant TB among household contacts in a high burden setting	6
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB	6
Factors associated with presenting to private sector care providers at the onset of TB symptoms	6
WHO drug-resistant TB guidelines 2022: what is new?	6
Bronchiectasis exacerbations: certainties and future challenges	6
TB screening of Ukrainian refugees in Germany	6
Cutaneous adverse drug reactions to fixed-dose combination treatments for TB	6
Glutathione and N-acetylcysteine in TB management	6
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing	6
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	6
Family directly observed therapy for children with drug-resistant TB	6
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs	6
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	5
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	5
Clinical outcomes in comorbid COVID-19 and TB cases	5
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	5
TB screening of children from Ukraine in Germany	5
Temporal trends in treatment strategies and outcomes of newly diagnosed Mycobacterium avium complex pulmonary disease	5
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	5
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	5
Evaluation of the MolecuTech® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	5
Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing	5
Implementation of modified, all-oral shorter TB regimens in Armenia	5
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	5
Potential use of nasopharyngeal aspirate for pediatric TB diagnosis	5
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	5
Accuracy of a fluorescent dye-qPCR for diagnosis of pulmonary TB in HIV-associated adults	5
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	5
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	5
TB screening, prevention and treatment cascade in a Malawi prison	5
Differentiated service delivery for TB treatment	5
Borderline T-SPOT.TB results: test reliability, patient characteristics, and TB progression	4
Bridging the gap: key evidence needed to strengthen global policies to end TB	4
Eosinophils in bronchiectasis: searching for a new endotype	4
Highlighting the characteristics of TB disease in older people	4
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	4
Predictive value of neutrophil-to-lymphocyte ratio in severe pulmonary infection: sex-specific cut-off values needed	4
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	4
Effect of HIV on bedaquiline and delamanid pharmacokinetics in patients with multidrug-resistant TB	4
Risk factors for the isolation of Haemophilus influenzae in patients with stable chronic obstructive pulmonary disease	4
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	4
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	4
Attrition in the treatment cascade among elderly patients with multidrug-resistant TB	4
Bridging the gap in TB diagnostic strategies between technical sophistication and real-world applicability in low-resource settings	4
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	4
Reducing stigma among vulnerable populations with TB: insights from a community intervention	4
SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB	4
Post-TB bronchiectasis: clinical characteristics and microbiology	4
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	4
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	4
Factors associated with referrals for directly observed treatment and unsuccessful treatment	4
Undernutrition assessment and nutrient intake of people with TB in the Philippines	4
Therapeutic drug monitoring for isoniazid and rifampicin exposure	4
Prevalence of and readiness to reduce alcohol use and smoking among adults with TB and HIV in Ukraine	4
A comprehensive person-centred TB care model, from malnutrition to mental health	4
Programmatic implications of a sub-national TB prevalence survey in India	4

Preventing household TB transmission with portable air cleaners and fans	4
Respiratory health of conch shell workers: insights from West Bengal, India	4
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19	3
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field	3
Anatomical and functional characteristics of symptomatic post-TB lung disease	3
Artificial intelligence for TB education and counselling: a modified Delphi consensus	3
Expanding the diagnosis of TB and nontuberculous infections using real-time PCR in fixed tissue	3
Isolation and purification of lipoarabinomannan from urine of adults with active TB	3
Prevalence, temporal trends and risk factors of drug-resistant TB in Zibo, China, 2018–2021	3
Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children	3
A comparison of bronchoalveolar lavage and gastric aspirate for diagnosis of paediatric TB	3
Association between chronic obstructive pulmonary disease and biomass smoke in rural areas	3
TB risk during treatment with biological agents and Janus kinase inhibitors: an umbrella review	3
TB in the elderly: clinical features and outcomes	3
The interplay between TB and lung cancer: risk, prognosis and treatment dynamics	3
Attitudes towards adjunctive surgical therapy for pulmonary TB in Europe: an ESGMYC, ESTS, and TBnet collaborative survey	3
TB and interstitial lung disease: a systematic review and meta-analysis	3
Successful rechallenge of rifabutin in rifampicin-induced thrombocytopenia during TB treatment	3
Work-related interstitial lung diseases: reassessing the burden	3
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	3
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	3
Contributions of GeneXpert® to TB diagnosis in Myanmar	3
Factors associated with screening failure and study withdrawal in multidrug-resistant TB	3
An adapted scale to measure perceived TB and HIV stigma during household contact investigation	3
Use of BPaL to treat RR/MDR-TB, pre-XDR-TB, and extensive disease: real-world outcomes from a cohort in Germany	3
Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda	3
Conjugated hyperbilirubinemia associated with accidental rifapentine overdose	3
Ukraine embraces innovation in its fight against another deadly foe: TB	3
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	3
Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting	3
Factors associated with pulmonary TB in malnourished children admitted to rehabilitation centres	3
Effect of community awareness, screening, testing, and treatment campaigns on TB prevention	3
Increasing trend of non-tuberculous mycobacteria in a Croatian hospital, 2012–2019	3
Ocular TB in Western Australia	3
Prevalence and determinants of chronic respiratory diseases in adults in Sudan	3
Preventing lung function decline and pleural thickening after pleural TB: a systematic review	3
Outcomes for people with TB by disease severity at presentation	3
Extra-pulmonary TB: a comparison between migrants and populations born in a low-incidence country	3
Factors influencing treatment outcomes in patients with isoniazid-resistant pulmonary TB	3
Cascade of TB care in Indigenous populations in South America: a scoping review	3
Comparing the MiniBox™ and the Chestac-8900® for pulmonary function testing	3
Characterising cause of death among people treated for drug-susceptible TB in India	3
Post-TB lung disease – the rationale for a Clinical Statement	3
The effect of medication event reminder monitoring on treatment adherence of TB patients	3
Outcomes of childhood TB in countries with a universal BCG vaccination policy	3
The economic burden of TB faced by patients and affected families in Papua New Guinea	3
Assessing air pollution exposure in children at school: toward a source-specific exposure matrix	3
The effect of TB patient delay on loss to follow-up in Portugal	3
Impact of processing delays on molecular detection of childhood pulmonary TB from gastric lavage samples	3
Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK	3
Understanding systematic rifampicin resistance errors with the FluoroType MTBDR VER 2.0	3